Novel highlight in malarial drug discovery: aspartate transcarbamoylase (2022)
- Authors:
- USP affiliated authors: WRENGER, CARSTEN - ICB ; KRÜGER, ARNE - ICB
- Unidade: ICB
- DOI: 10.3389/fcimb.2022.841833
- Subjects: PARASITOLOGIA; ASPARTATO CARBAMOILTRANSFERASE; ANTIMALÁRICOS; MALÁRIA; COMPOSTOS ORGÂNICOS; PLASMODIUM FALCIPARUM; AMINOÁCIDOS; CRISTALOGRAFIA DE RAIOS X
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Cellular and Infection Microbiology
- ISSN: 2235-2988
- Volume/Número/Paginação/Ano: v. 12, art. 841833, p. 1-9, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
WANG, Chao et al. Novel highlight in malarial drug discovery: aspartate transcarbamoylase. Frontiers in Cellular and Infection Microbiology, v. 12, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2022.841833. Acesso em: 11 fev. 2026. -
APA
Wang, C., Krüger, A., Du, X., Wrenger, C., & Groves, M. R. (2022). Novel highlight in malarial drug discovery: aspartate transcarbamoylase. Frontiers in Cellular and Infection Microbiology, 12, 1-9. doi:10.3389/fcimb.2022.841833 -
NLM
Wang C, Krüger A, Du X, Wrenger C, Groves MR. Novel highlight in malarial drug discovery: aspartate transcarbamoylase [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-9.[citado 2026 fev. 11 ] Available from: https://doi.org/10.3389/fcimb.2022.841833 -
Vancouver
Wang C, Krüger A, Du X, Wrenger C, Groves MR. Novel highlight in malarial drug discovery: aspartate transcarbamoylase [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-9.[citado 2026 fev. 11 ] Available from: https://doi.org/10.3389/fcimb.2022.841833 - Discovery of small-molecule allosteric inhibitors of PfATC as antimalarials
- Aptamer applications in emerging viral diseases
- Inibidores da via de síntese de vitamina B6 entregues por associação com nanopartículas contra Plasmodium spp
- High target homology does not guarantee inhibition: aminothiazoles emerge as inhibitors of Plasmodium falciparum
- Transporter-mediated solutes uptake as drug target in Plasmodium falciparum
- Oxidative stress in human infectious diseases - present and current - knowledge about its druggability
- Purification, crystallization and preliminary X-ray diffraction analysis of pyridoxal kinase from Plasmodium falciparum (PfPdxK)
- Exploring inhibition of Pdx1, a component of the PLP synthase complex of the human malaria parasite Plasmodium falciparum
- Trafficked Proteins—Druggable in Plasmodium falciparum?
- In vitro activity of extracts and isolated polyphenols from West African medicinal plants against Plasmodium falciparum
Informações sobre o DOI: 10.3389/fcimb.2022.841833 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Novel Highlight in Malari... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
